SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
Launched by UNIVERSITY HOSPITAL, BREST · Aug 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how comfortable patients are with biopsies, which are small tissue samples taken from the body to help diagnose autoimmune diseases. The researchers want to understand how well patients tolerate these biopsies, specifically from the salivary glands, temporal arteries, and neuromuscular areas, and how informed they feel about the process.
To participate in this trial, you need to be at least 18 years old and require a biopsy for diagnosis or follow-up of your condition. Unfortunately, if you have difficulty understanding or cannot give consent, or if you are under legal protection and refuse to participate, you won’t be able to join. If you decide to participate, you can expect to share your experience with the biopsy process, helping doctors learn more about how to improve patient care in the future. Your feedback will be valuable in making this procedure more comfortable for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • biospy required for the diagnsis or follow up aged of more than 18 non opposition form
- Exclusion Criteria:
- • unable to consent demencia unable to fill the form and questionnaire patient Under juridical protection refusing to participate
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, , France
Angers, , France
Brest, , France
Marseille, , France
Paris, , France
Lille, , France
Tours, , France
Quimper, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials